Loss, Alexis J PA

The Institute for Neurodegenerative Disorders (IND) at Yale Medicine is dedicated to advancing diagnostic tools and treatments for patients with neurodegenerative conditions through clinical research. IND operates as a leading clinical and imaging research facility, focusing on developing innovative neuroimaging tools to detect conditions before symptoms arise, provide accurate diagnoses, and monitor disease progression. With a team of expert researchers, including neurologists, nurses, and study coordinators, IND conducts research on Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease, and other neurologic conditions. Their cutting-edge brain imaging research utilizes advanced technologies such as Positron Emission Tomography (PET) and Single Photon Emission Computerized Tomography (SPECT) to enhance understanding and treatment of these disorders. Through strategic partnerships with organizations such as The Michael J. Fox Foundation, IND collaborates globally to accelerate the development of diagnostic tools and treatments. The institute envisions a future where early detection, effective treatment, and even prevention of neurologic conditions are possible, striving to make a meaningful impact in the field of neurodegenerative research. Generated from the website content